Dragon Pharma — Oral Steroids and Performance Tabs
25 oral products spanning mass building AAS, lean mass compounds, cutting agents, thyroid and metabolic support, and specialty compounds — all independently third-party tested for compound identity and dosage accuracy.
Oral Products
Showing 1–25 of 25 results
Dragon Pharma Oral Products — 25 Compounds
The Dragon Pharma oral range covers five compound categories across 25 products — from classic anabolic mass builders through lean mass compounds, body composition agents, thyroid and metabolic support, and specialty performance compounds. All oral products are independently tested for compound identity and dosage accuracy before release.
Mass Building — 17-Alpha-Alkylated AAS
The highest-potency oral anabolics: Dianabol 20 and Dianabol 50 (Methandienone) for rapid mass and strength; Anadrol (Oxymetholone) — the strongest oral AAS with anabolic ratio 320; Superdrol (Methyldrostanolone) for dry mass without aromatisation; M1T (Methyl-1-Testosterone) — the most potent oral per milligram in the range; Halotestin for strength without mass; Oral Tren (Methyltrienolone) and Cheque Drops for extreme pre-competition androgenic priming.
Lean Mass and Cutting AAS
Anavar 10 and Anavar 50 (Oxandrolone) — the mildest oral AAS, non-aromatising, lean mass and strength with minimal suppression; Winstrol 10 and Winstrol 50 (Stanozolol) for lean mass and hardness; Turanabol (4-Chlorodehydromethyltestosterone) for lean gains without water retention.
Fat Loss, Thyroid and Metabolic Agents
Clenbuterol — beta-2 agonist for lipolysis and metabolic elevation; T3 Liothyronine and T4 Levothyroxine for thyroid-mediated metabolic rate enhancement; CYT3 — triple-agent fat loss combination (Clenbuterol + Yohimbine + T3); Sibutramine for appetite suppression; Salbutamol as the milder beta-2 agonist alternative to Clenbuterol.
Specialty and Support Compounds
MK-677 Ibutamoren — oral GH secretagogue elevating GH and IGF-1 without suppression; Enclomiphene — selective estrogen receptor modulator for testosterone support without the side effects of mixed-isomer Clomid; Raloxifene — SERM for gynecomastia management; Accutane (Isotretinoin) for severe acne management; Finasteride for DHT reduction and hair loss prevention; Atorvastatin for lipid management during AAS cycles; Minoxidil for hair retention support.
17-AA Hepatotoxicity — What You Need to Know
Most oral AAS in this range are 17-alpha-alkylated — a structural modification that allows oral bioavailability but produces first-pass hepatic stress. ALT and AST enzyme elevation is expected during 17-AA oral AAS use. Practical guidelines: limit 17-AA oral cycles to 4-6 weeks maximum; use TUDCA or UDCA for bile acid support during cycles; monitor liver enzymes with mid-cycle and post-cycle blood panels; allow adequate time between oral cycles for hepatic recovery. Exceptions — Anavar (Oxandrolone) is notably milder hepatically than most 17-AA orals; Primobolan oral (Methenolone Acetate) is the mildest of the range.
Frequently Asked Questions
Dianabol (Methandienone) is the most widely used oral for mass building — fast-acting, significant lean mass and strength gains within 2-3 weeks, available at 20mg and 50mg tablets. Anadrol (Oxymetholone) produces the most dramatic mass gains of any oral AAS — anabolic ratio 320 — but with significant estrogenic effects and hepatotoxicity. Superdrol produces dry mass without aromatisation, often preferred when estrogen management is a priority.
Anavar (Oxandrolone) is the most commonly used lean mass oral — non-aromatising, mild hepatotoxicity, strength and lean mass without water retention. Winstrol (Stanozolol) is the standard hardening and vascularity oral for cutting phases. Turanabol provides lean gains similar to mild Dianabol without water retention. All three are non-aromatising — no AI needed for the oral compound itself.
Most 17-alpha-alkylated oral AAS should be limited to 4-6 weeks per cycle due to hepatotoxicity — Dianabol, Anadrol, Winstrol, Superdrol, Halotestin, M1T and Oral Tren all carry significant first-pass liver stress. Anavar is commonly run for 6-8 weeks due to its relatively milder hepatic profile. Exceptions include non-17-AA oral compounds: MK-677 (no hepatotoxicity limit) and Proviron (C1-methylated, no hepatotoxicity) can be run for extended periods.
Technically yes — but not recommended for most oral AAS. All oral AAS suppress the HPG axis, reducing natural testosterone production. Without a testosterone base, androgenic support falls to zero during suppression, causing low testosterone symptoms (low libido, fatigue, mood issues). Anavar at low doses (20-30mg) is the most commonly used standalone oral due to its mild suppression. MK-677 and Cardarine (non-suppressive) are the exception — these can be used as true standalone oral protocols without testosterone base.
MK-677 (Ibutamoren) is an oral GH secretagogue — it stimulates GH and IGF-1 release through GHS-R1a receptor agonism (the same receptor as GHRP peptides) but via an oral tablet. Unlike AAS, it produces no testosterone suppression and requires no PCT. It is listed in the oral category because its administration route is oral daily dosing — distinct from the injectable peptide GHRP/GHRH compounds in the Peptides category despite sharing the same receptor mechanism.